Comparison of two injection techniques using botulinum toxin in spastic hemiplegia

American Journal of Physical Medicine and Rehabilitation

Volumn 75, Issue 6, 1996, Pages 462-469

  Childers, Martin K ^a,d   Stacy, Mark ^b   Cooke, Deborah L ^a   Stonnington, Henry H ^c  

^a University of Missouri   (United States)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

^c MEMORIAL HEALTH UNIVERSITY MEDICAL CENTER   (United States)

^d 501 Rusk Rehabilitation Center ^*  (United States)

Author keywords

Botulinum Toxin; Gait; Hemiplegia; Spasticity

Indexed keywords

ACUTE VASCULAR OCCLUSION (AVO); BOTULINUM TOXIN; CHRONIC SPASTIC HEMIPLEGIC GAIT; GASTROCNEMIUS MUSCLES;

ELECTROMYOGRAPHY; MUSCLE; MUSCULOSKELETAL SYSTEM; NEUROLOGY; PATIENT TREATMENT; PHYSICAL THERAPY;

DRUG INFUSION;

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; GAIT; GASTROCNEMIUS MUSCLE; HEMIPLEGIA; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MUSCLE SPASM; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM;

ADULT; AGED; ANKLE JOINT; BOTULINUM TOXINS; DOUBLE-BLIND METHOD; FEMALE; HEMIPLEGIA; HUMANS; INJECTIONS; JOINT INSTABILITY; MALE; MIDDLE AGED; MUSCLE SPASTICITY; PROSPECTIVE STUDIES;

EID: 0030292338     PISSN: 08949115     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002060-199611000-00013     Document Type: Article

References (29)

1. Snow BJ, Tsui JK, Bhatt MH, Varelas M, Hashimoto SA, Calne DB: Treatment of spasticity with botulinum toxin: a double-blind study. Ann Neurol 1990;28:512-515.
2. Das TK, Park DM: Botulinum toxin in treating spasticity. Br J Clin Pract 1989;43:401-403.
3. Das TK, Park DM: Effect of treatment with botulinum toxin on spasticity. Post Med J 1989;65:208-210.
4. Borg-Stein J, Pine ZM, Miller JR, Brin MF: Botulinum toxin for the treatment of spasticity in multiple sclerosis. New observations. Am J Phys Med Rehabil 1993;72:364-368.
5. Koman LA, Mooney JF, Smith B, Goodman A, Mulvaney T: Management of cerebral palsy with botulinum-A toxin: preliminary investigation. J Pediatr Orthop 1993;13:489-495.
6. Dengler R, Neyer U, Wohlfarth K, Bettig U, Janzik HH: Local botulinum toxin in the treatment of spastic drop foot. J Neurol 1992;239:375-378.
7. Hesse S, Lucke D, Malezic M, et al.: Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients. J Neurol Neurosurg Psychiatry 1994;57:1321-1324.
8. Dunne JW, Heye N, Dunne SL: Treatment of chronic limb spasticity with botulinum toxin A. J Neurol Neurosurg-Psychiatry 1995;58:232-235.
9. Grazko MA, Polo KB, Jabbari B: Botulinum toxin A for spasticity, muscle spasms, and rigidity. Neurology 1995;45: 712-717.
10. Memin B, Pollak P, Hommel M, Perret J: Treatment of spasticity with botulinum toxin. Rev Neurol (Paris) 1992;148: 212-214.
11. Agana BT, Yablon SA: Clinical effectiveness of botulinum toxin in distal upper extremity spasticity among patients with brain injury (abstract). Arch Phys Med Rehabil 1994;75:1063.
12. Pierson SH: Botulinum toxin A (BTA) in the treatment of spasticity (abstract). Neurology 1994;44:15.
13. Konstanzer A, Ceballos-Baumann AO, Dressnandt J, Conrad B: Botulinum toxin A treatment in spasticity of arm and leg (abstract). Mov Disord 1992;7:416.
14. Singh B, Shahwen SA, Miller VS, Rida AR: Use of botulinum toxin for adductor spasticity in cerebral palsy (abstract). Ann Neurol 1994;36:513.
15. O'Brien CF: A randomized, double-blind, placebo-controlled study to evaluate the use of botulinum toxin type A in the treatment of spasticity (abstract). Neurology 1996; 46:1306-1310.
16. Borodic GE, Ferrante R, Pearce LB, Smith K: Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections. Mov Disord 1994;9:31-39.
17. Shaari CM, Sanders I: Quantifying how location and dose of botulinum toxin injections affect muscle paralysis. Muscle Nerve 1993;16:964-969.
18. Coers C: The Innervation of Muscle. Springfield, IL: Charles Thomas, 1959.
19. Coers C: Structural organization of the motor nerve endings in mammalian muscle spindles and other striated muscle fibers. Am J Phys Med Rehabil 1958;38:166-175.
20. Awad EA, Awad OE: Injection Techniques for Spasticity. Minneapolis, MN, EA Awad, MD, PA, 1993.
21. Fugl-Meyer AR, Jaasko L, Leyman I, Olsson S, Steglind S: The post-stroke hemiplegic patient. 1. a method for evaluation of physical performance. Scand H Rehabil Med 1975;7:13-31.
22. Ashworth B: Preliminary trial of carisoprodol in multiple sclerosis. Practitioner 1964;162:540.
23. Norkin CC, White DJ: Measurement of Joint Motion: A Guide to Goniometry. Philadelphia: FA Davis, 1994.
24. Daniel WW: Applied Nonparametric Statistics. Boston, PWS-KENT, 1990.
25. Dykstra DD, Sidi AA: Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study. Arch Phys Med Rehabil 1990;71:24-26.
26. Jankovic J, Brin MF: Therapeutic uses of botulinum toxin (review). N Engl J Med 1991;324:1186-1194.
27. Noort S, Altrocchi P, Brin MF, et al.: Assessment: the clinical usefulness of botulinum toxin-A in treating neurologic disorders. Neurology 1990;40:1332-1336.
28. 125I-labelled botulinum A neurotoxin: pharmacokinetics in cats after intramuscular injection. Naunyn Schmiedebergs Arch Pharmacol 1976;292:161-165.
29. Priori A, Berardelli A, Mercuri B, Manfredi M: Physiological effects produced by botulinum toxin treatment of upper limb dystonia. Brain 1995;118:801-807.